JACKSON, Miss. (AP) – Mississippi’s top public health official said Tuesday that he’s telling health care providers to refrain from using the Johnson & Johnson COVID-19 vaccine while federal agencies investigate reports of potentially dangerous blood clots.
Dr. Thomas Dobbs said health care providers should wait for “additional guidance” from the Centers for Disease Control and Prevention and the Food and Drug Administration.
Dobbs also wrote on Twitter: “Those who have received JnJ already should not be worried.”
The CDC and the FDA said Tuesday they were investigating unusual clots that occurred 6 to 13 days after vaccination. The clots occurred in veins that drain blood from the brain and occurred together with low platelets. All six cases were in women between the ages of 18 and 48; there was one death and all remained under investigation.
The reports appear similar to a rare, unusual type of clotting disorder that European authorities say is possibly linked to another COVID-19 vaccine not yet cleared in the U.S., from AstraZeneca.
More than 6.8 million doses of the J&J; vaccine have been administered in the U.S., the vast majority with no or mild side effects.
Dobbs said records show 38,885 doses of the Johnson & Johnson vaccination have been given in Mississippi. That is about 2.7% of the 1,456,187 doses of COVID-19 vaccine given in state.
Follow AP’s coverage of the pandemic at https://apnews.com/hub/coronavirus-pandemic and https://apnews.com/UnderstandingtheOutbreak.
Copyright © 2021 The Washington Times, LLC.